查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1694028

中国医药包装：市场占有率分析、产业趋势与统计、成长预测（2025-2030）

China Pharmaceutical Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 100 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2025年中国医药包装市场规模为208.4亿美元，到2030年预计将达到289.3亿美元，预测期内（2025-2030年）的复合年增长率为6.78%。

中国医药包装市场-IMG1

中国医药产业的成长为中国医药包装企业创造了机会。鼓励中国医药包装企业发展研发团队，探索创新、绿色、安全、功能性和永续的包装材料和产品。

关键亮点

  • 中国政府推动医疗产业转型的措施预计将推动医药包装产业的发​​展。中国正积极升级医药包装设施和材料，推动药品多元化发展，为医药包装企业带来新的机会。
  • 中国製药业在由中国食品药物监督（CFDA）和国家监督监督管理局（NMPA）等机构执行的严格监管标准框架内运作。这些标准涵盖了包装设计、材料成分、标籤要求和安全通讯协定等各个方面。遵守这些标准是不可协商的，并且需要在包装实践中一丝不苟地关注细节。
  • 奈米技术可以开发奈米结构材料，透过保护药物免受光、湿气和氧气等环境因素的影响，提高药物的稳定性。这可提高药品的保存期限和疗效。奈米技术正在推动智慧包装解决方案的发展，该解决方案可以监测药品状况并提供有关温度、湿度和光照等因素的即时回馈。这有助于确保药品整个生命週期的品质和功效。
  • 在医药包装市场，瓶子、管瓶、泡壳包装和标籤等原料对于包装材料的生产至关重要。原料供应商拥有很大的议价能力，尤其是当他们占据市场主导地位或原料供应短缺时。他们可以利用这种权力提高价格或对药品包装製造商施加不利条款。因此，包装材料的生产成本可能会增加。
  • 塑胶包装凭藉其轻盈、耐用、多功能和成本效益等优势，已成为包装行业中一股强大的力量。塑胶包装广泛应用于医疗、保健等需要包装支撑的各个产业。中国材料包装发展历史悠久，已形成完善的产业链。在这个链条中，上游环节由原料供应商组成，负责供应生产塑胶包装材料的合成树脂和塑胶添加剂。

中国医药包装市场趋势

柏林仓库总量领先

  • 随着中国建立了製药业的标准框架，中国药用玻璃安瓿瓶和管瓶市场预计将扩大。在国内，医药包装材料在药品储存过程中的稳定性以及包装使用时的安全性越来越受到重视。由于玻璃包装具有耐用性、非反应性、透明度、环境相容性和多功能性，製药公司越来越多地采用玻璃包装。此外，医疗保健系统投资的增加、研发的增加以及医药支出的增加正在推动对管瓶的需求。
  • 特别是过去几年与COVID-19疫情相关的药品和疫苗需求，导緻管瓶和安瓿瓶的需求增加。药品和肠外包装製造商正在大幅提高生产能力。由于製造商满载运作，每月可生产数百万个小管瓶和安瓿瓶。
  • 根据美国有线电视新闻网（CNN）报道，截至2023年3月，全球已接种约130亿剂新冠疫苗，其中中国当地约占34.91亿剂。
  • 玻璃管瓶和安瓿瓶在已开发国家的应用越来越广泛。受新冠疫情影响，新兴国家的医疗保健和製药业正在成长，凸显了中国市场的潜力。此外，在该地区营运的公司正致力于提高生产能力。
  • 同样，製药和生命科学终端用户对管瓶和安瓿瓶的需求也在上升。由于需求波动，市场持续青睐这些终端用户，因此参与企业正集中精力推出新产品。
  • 2023 年 10 月，玻璃先驱肖特推出了下一代 I 型硼硅酸玻璃管。新产品和相关服务支持製药业的三大关键趋势：复杂药物开发、永续性数位化。製药公司使用该公司的玻璃管生产高品质的管瓶、安瓿瓶、注射器和药筒，用于储存简单和复杂的药物。特别是，该公司认为未来生物製药的需求将会增加，包装和材料必须满足更严格的要求和规定。

时尚服饰板块引领收益

  • 折迭纸盒是最受欢迎的二次包装产品类型。这些纸箱用途广泛，可以用于多种用途。折迭式纸盒具有多种优点，包括灵活性、刚性以及简单、经济的平板包装运输和储存。折迭式盒包装可保护药品免受光、湿气和污染等外部因素的影响，确保药品的安全。这种保护可保持药物的功效和完整性。在製药业，引入无线射频识别（RFID）智慧标籤技术来防止产品克隆也将有助于市场扩张。
  • 由于行业竞争激烈，对印刷药品纸盒的需求正在增加。这些纸盒提供了充足的空间用于发布监管讯息和品牌广告，并且比小瓶、管瓶和容器提供了更多的标籤空间。最新的印刷药品包装市场创新融合了防篡改和儿童防护功能。这些功能得益于先进的材料技术和设计，进一步推动了对印刷药品纸盒的需求。
  • 服药依从性差的问题普遍存在，导致慢性疾病併发症和医疗费用增加。为了解决这个问题，药盒和泡壳包装等包装已广泛推广，扩大了此类产品的市场。
  • 药盒是一种可重复使用的多隔间容器，用于存放特定时间应服用的药物。与泡壳包装不同，它们可以由患者、非正式看护者或医疗保健提供者填充，而无需专家干预。对于患有多种慢性病的老年人，一些医疗保健提供者建议使用泡壳包装、药盒和折迭式纸盒作为包含药物资讯的二次包装。
  • 从成长前景和市场规模来看，中国医药市场仍然是最重要的市场之一。保险覆盖范围的扩大、人口老化、医疗需求高的中阶的不断壮大以及慢性病是成长的主要原因。
  • 根据国际糖尿病联盟预测，2045年华人成年人糖尿病盛行率将达12.5%。泡壳包装是中国最常用的药品包装。大型製药公司使用坚固且用途广泛的纸盒包装来保护泡壳。因此，随着药品泡壳包装的成长，折迭纸盒的需求也预计会增加。

中国医药包装市场概况

中国医药包装市场由全球企业和中小企业高度细分。市场的主要企业包括格雷斯海姆双峰药用玻璃（丹阳）（Gerresheimer AG）、West Pharmaceutical Services Inc.、台山新华药用包装、宁波正利药用包装和 Amcor Group GMBH。市场参与企业正在采取联盟和收购等策略来增强其产品供应并获得可持续的竞争优势。

  • 2023 年 11 月—全球公认的永续包装解决方案供应商 Amcor 宣布了其医疗层压解决方案的最新进展。这种创新产品有助于在聚乙烯回收流中创造完全可回收的全薄膜包装。透过大幅减少最终包装的碳排放，这项新解决方案满足了医疗设备应用的基本性能标准，同时支持医疗公司在不损害患者安全的情况下实现其永续发展目标。

其他福利

  • Excel 格式的市场预测 (ME) 表
  • 3个月的分析师支持

目录

第一章 引言

  • 研究假设和市场定义
  • 研究范围

第二章调查方法

第三章执行摘要

第四章 市场洞察

  • 市场概览
  • 生态系分析
  • 产业吸引力-波特五力分析
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争对手之间的竞争
  • 医药包装产业法规、政策及标准
  • 医药包装产业的最新创新和新产品开发趋势
  • 原料分析

第五章市场动态

  • 市场驱动因素
    • 包装监管标准和严格的仿冒品措施
    • 奈米技术对新一代创新包装解决方案的影响
  • 市场限制
    • 供应商议价能力导致原物料成本波动

第六章新兴趋势分析与关键成功因素

第七章市场区隔

  • 按初级包装
    • 药用塑胶瓶
    • 瓶子和罐子
    • 泡壳包装
    • 预灌封注射器
    • 管瓶和安瓿瓶
    • 点滴容器
    • 预充式吸入器
    • 其他初级包装产品（袋、管、盖、封口等）
  • 透过二次包装
    • 折迭式盒和纸盒（纸质）
    • 纸板（纸本）
    • 袋子/小袋（软）
    • 泡壳（纸塑）
    • 其他二次包装产品（托盘、标籤等）

第八章竞争格局

  • 公司简介
    • Gerresheimer Shuangfeng Pharmaceutical Glass（Danyang）Co. Ltd（Gerresheimer AG）
    • West Pharmaceutical Services Inc.
    • Taishan Xinhua Pharmaceutical Packaging Co. Ltd
    • Ningbo Zhengli Pharmaceutical Packaging
    • Amcor Group GMBH
    • Perlen Packaging（Suzhou）Co. Ltd
    • Shandong Pharmaceutical Glass Co. Ltd
    • Yuhuan Kang-jia Enterprise Co. Ltd
    • Dongguan Fukang Plastic Products Co. Ltd
    • JOTOP Glass
    • Jiangsu Hanlin Pharmaceutical Packaging
    • Hangzhou Xunda Packaging Co., Ltd.
    • Luoyang Dirante Pharmaceutical Packaging Material Co. Ltd
  • Share of China Pharmaceutical Packaging Companies in Global Market

第九章 投资展望

第十章：市场的未来

简介目录
Product Code: 50002077

The China Pharmaceutical Packaging Market size is estimated at USD 20.84 billion in 2025, and is expected to reach USD 28.93 billion by 2030, at a CAGR of 6.78% during the forecast period (2025-2030).

China Pharmaceutical Packaging - Market - IMG1

The growth of the Chinese pharmaceutical sector creates business opportunities for the country's pharmaceutical packaging companies. China's pharmaceutical packaging firms are encouraged to develop research and development teams to explore innovative, environmentally friendly, safe, functional, and sustainable packaging materials and products.

Key Highlights

  • The Chinese government's policies to advance the transformation of the country's medicine industry are expected to promote the development of the pharmaceutical packaging sector. China is actively upgrading its pharmaceutical packaging facilities and materials and diversifying its pharmaceutical products, bringing new opportunities to pharmaceutical packaging firms.
  • The Chinese pharmaceutical industry operates within a framework of stringent regulatory standards enforced by authorities such as the China Food and Drug Administration (CFDA) and the National Medical Products Administration (NMPA). These standards encompass various aspects of packaging design, material composition, labeling requirements, and safety protocols. Compliance with these standards is non-negotiable and requires meticulous attention to detail in packaging practices.
  • Nanotechnology enables the development of nanostructured materials that can enhance the stability of drugs by protecting them from environmental factors such as light, moisture, and oxygen. This leads to increased shelf-life and efficacy of pharmaceutical products. Nanotechnology enables the development of smart packaging solutions that can monitor the condition of the drug and provide real-time feedback on factors such as temperature, humidity, and exposure to light. This helps ensure the quality and efficacy of pharmaceutical products throughout their lifecycle.
  • In the pharmaceutical packaging market, raw materials such as bottles, vials, blister packs, and labels are essential for manufacturing packaging materials. Suppliers of raw materials wield significant bargaining power, especially when they hold a dominant position in the market or when the raw material is scarce. They can leverage this power to increase prices or impose unfavorable terms on pharmaceutical packaging manufacturers. This, in turn, can lead to higher production costs for packaging materials.
  • Plastic packaging has emerged as a formidable player in the packaging industry due to its advantageous properties, such as lightweight, high durability, versatility, and cost-effectiveness. It has widespread application in various industries, including medicine, healthcare, and other sectors requiring packaging support. The development of material packaging in China has a rich history and has matured into a well-established industrial chain. In this chain, the upstream sector comprises raw material suppliers responsible for providing synthetic resins and plastic additives for manufacturing plastic packaging materials.

China Pharmaceutical Packaging Market Trends

Berlin Leads in Total Warehousing Take-up

  • The Chinese pharmaceutical glass ampoules and vials market is expected to expand as China has established a standard framework for the pharmaceutical industry. The country is increasingly focusing on the stability of pharmaceutical packaging materials during drug storage and the safety of the packaging when used. Pharmaceutical companies increasingly use glass packaging because of its durability, non-reactivity, transparency, eco-friendliness, and versatility. Additionally, glass vials are in high demand due to increasing investment and R&D in healthcare systems and rising drug spending.
  • Notably, the demand for vials and ampoules has grown due to the demand for medications and vaccinations related to the COVID-19 pandemic in the past few years. Manufacturers of pharmaceutical and parenteral packaging have greatly boosted their capacity for production. Millions of vials and ampoules are produced monthly by manufacturers operating at full capacity.
  • According to CNN, as of March 2023, approximately 13 billion COVID-19 vaccine doses had been administered globally, with Mainland China accounting for almost 3.491 billion of this total.
  • Glass vials and ampoules are becoming more widely used in developed countries. As a result of COVID-19, the healthcare and pharmaceutical sectors are growing in emerging nations, which presents the potential for the Chinese market. Additionally, players operating in the region focus on increasing their production capacity.
  • Similarly, the demand for vials and ampoules among end users of pharmaceutical and life sciences is increasing. The market continues to favor these end users for demand variation, so players are concentrating on launching new products.
  • In October 2023, the glass pioneer SCHOTT introduced next-generation type I Borosilicate glass tubing. This new product and its associated services will support three key trends in the pharma industry: the development of complex pharmaceuticals, sustainability, and digitalization. Pharmaceutical converters use the company's glass tubing to produce high-quality vials, ampoules, syringes, or cartridges to store simple and complex drugs. In particular, the company sees an increasing demand for biopharmaceutical products in the future, where packaging and materials will need to meet more stringent requirements and regulations.

Fashion and Apparel Segment to Lead in Revenue

  • Folding cartons constitute the most popular type of secondary packaging product. These cartons are versatile and can be used in many ways. Folding cartons offer several advantages, including flexibility, rigidity, and easy and cost-effective flat-pack shipping and storage. The folding box packaging ensures the safety of pharmaceutical products by protecting them from external factors like light, moisture, and contamination. This protection helps preserve the potency and integrity of the medications. Implementing radio-frequency identification (RFID) smart labeling technology to prevent product replication in the pharmaceutical industry will also contribute to market expansion.
  • The demand for printed pharmaceutical cartons is rising due to the industry's stiff competition. In addition to providing ample space for regulatory information and brand advertising, these cartons also offer more room than small bottles, vials, and containers. The latest printed pharmaceutical packaging market innovation incorporates tamper-evident and child-proof features. These features are achieved through advanced material technology and design, further driving the demand for pharmaceutical printed cartons.
  • The problem of inadequate medication adherence is prevalent, leading to an increase in chronic disease complications and healthcare expenditures. Packaging interventions such as pillboxes and blister packs have been widely recommended to address this issue, leading to a growing market for such products.
  • Pillboxes are reusable multi-compartment containers designed to hold medications to be consumed at specific times. Unlike blister packs, they do not require professional action and can be filled by patients, informal caregivers, or healthcare providers. Multiple healthcare providers recommend using blister packs, pillboxes, and folding cartons as secondary packaging with medication information for the aging with multiple chronic diseases.
  • The Chinese pharmaceutical market is still one of the most important in terms of growth prospects and market size. The expansion of insurance coverage, the aging population, the growing middle class with higher healthcare needs, and chronic diseases are the main reasons for this growth.
  • According to the International Diabetes Federation, the forecasted prevalence of diabetes among adults in China will be 12.5 % by 2045. Blister packaging is the most common type of pharmaceutical packaging used in China. Major pharmaceutical companies use sturdy and versatile folding carton packaging to protect the blister. Therefore, with the growth of pharmaceutical blister packaging, there would be a consequent growth in demand for folding cartons.

China Pharmaceutical Packaging Market Overview

The Chinese pharmaceutical packaging market is highly fragmented due to global players and small and medium-sized enterprises. Some of the major players in the market are Gerresheimer Shuangfeng Pharmaceutical Glass (Danyang) Co. Ltd (Gerresheimer AG), West Pharmaceutical Services Inc., Taishan Xinhua Pharmaceutical Packaging Co. Ltd, Ningbo Zhengli Pharmaceutical Packaging, and Amcor Group GMBH. Market players are adopting strategies such as partnerships and acquisitions to enhance their product offerings and gain sustainable competitive advantage.

  • November 2023 - Amcor, a renowned global provider of sustainable packaging solutions, launched its latest advancement in Medical Laminates solutions. This innovative offering facilitates the creation of fully recyclable, all-film packaging within the polyethylene recycling stream. By significantly reducing the carbon footprint of the final package, this new solution meets the performance standards essential for medical device applications while supporting medical companies in advancing their sustainability objectives without compromising patient safety.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Ecosystem Analysis
  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Buyers
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Threat of Substitutes
    • 4.3.5 Intensity of Competitive Rivalry
  • 4.4 Industry Regulations, Policies, and Standards for Pharmaceutical Packaging
  • 4.5 Recent Innovations and New Product Development in the Pharmaceutical Packaging Industry
  • 4.6 Raw Material Analysis

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Regulatory Standards on Packaging and Stringent Norms Against Counterfeit Products
    • 5.1.2 Impact of Nanotechnology due to Innovative and New-generation Packaging Solutions
  • 5.2 Market Restraints
    • 5.2.1 Fluctuations in Raw Material Cost due to Suppliers' Bargaining Power

6 EMERGING TREND ANALYSIS AND KEY SUCCESS FACTORS

7 MARKET SEGMENTATION

  • 7.1 By Primary Packaging
    • 7.1.1 Pharmaceutical Plastic Bottles
    • 7.1.2 Bottles and Jars
    • 7.1.3 Blister Packaging
    • 7.1.4 Pre-fillable Syringes
    • 7.1.5 Vials and Ampoules
    • 7.1.6 IV Containers
    • 7.1.7 Prefillable Inhalers
    • 7.1.8 Other Primary Packaging Products (Pouches, Tubes, Caps, Closures, Etc.)
  • 7.2 By Secondary Packaging
    • 7.2.1 Folding Boxes and Cartons (Paper-based)
    • 7.2.2 Corrugated Shipping Containers (Paper-based)
    • 7.2.3 Bags and Pouches (Flexible)
    • 7.2.4 Clamshells (Paper and Plastic)
    • 7.2.5 Other Secondary Packaging Products (Trays, Labels among Others)

8 COMPETITIVE LANDSCAPE

  • 8.1 Company Profiles
    • 8.1.1 Gerresheimer Shuangfeng Pharmaceutical Glass (Danyang) Co. Ltd (Gerresheimer AG)
    • 8.1.2 West Pharmaceutical Services Inc.
    • 8.1.3 Taishan Xinhua Pharmaceutical Packaging Co. Ltd
    • 8.1.4 Ningbo Zhengli Pharmaceutical Packaging
    • 8.1.5 Amcor Group GMBH
    • 8.1.6 Perlen Packaging (Suzhou) Co. Ltd
    • 8.1.7 Shandong Pharmaceutical Glass Co. Ltd
    • 8.1.8 Yuhuan Kang-jia Enterprise Co. Ltd
    • 8.1.9 Dongguan Fukang Plastic Products Co. Ltd
    • 8.1.10 JOTOP Glass
    • 8.1.11 Jiangsu Hanlin Pharmaceutical Packaging
    • 8.1.12 Hangzhou Xunda Packaging Co., Ltd.
    • 8.1.13 Luoyang Dirante Pharmaceutical Packaging Material Co. Ltd
  • 8.2 Share of China Pharmaceutical Packaging Companies in Global Market

9 INVESTMENT OUTLOOK

10 FUTURE OF THE MARKET